Diagnostic Value of Serum Acid-Labile Subunit Alone and in combination with IGF-I and IGFBP-3 in the Diagnosis of Growth Hormone Deficiency
- 1 February 2021
- journal article
- research article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 93 (6), 371-379
- https://doi.org/10.1159/000512336
Abstract
Background: The acid-labile subunit (ALS) is a crucial factor in the tertiary complex. IGF-I and IGFBP-3 are routinely measured during the diagnostic work-up for growth hormone deficiency (GHD). The aim of the study is to evaluate the relevance of serum ALS as an additional biomarker in the diagnosis of GHD. Methods: Ninety-one children undergoing standard diagnostic work-up for GHD were included in this retrospective study. Inclusion criteria were evidence-based auxological cutoffs, IGF-I and IGFBP-3 <-2 SDS at first presentation, at least 1 growth hormone (GH) stimulation test, and IGF-I, IGFBP-3, and ALS measurements on the same day. Statistical analysis was performed by ROC as well as by odds ratio calculations. Results: Forty-seven of 90 participants presented with peak GH values under the cutoff of 7 ng/mL. AUC from a model containing only IGF-I was 0.76 and 0.68 when using only ALS. A model containing IGF-I, IGFBP-3, and ALS (AUC = 0.77) did not improve the result compared to the combination of IGF-I/IGFBP-3 (0.77) or IGF-I/ALS (0.76). Furthermore, the variation in the outcome (GH peak = 7) explained by IGF-I only amounts to 20.4%, while that explained by IGFBP-3 and ALS is only 10.6 and 7.8%, respectively. The sensitivity to diagnose GHD at respective concentrations of -2.0 SDS was 48% for IGF-I, 38% for IGFBP-3, and only 8% for ALS. Conclusion: Determination of serum ALS alone or in combination with IGF-I and IGFBP-3 did not improve definition of biochemical GHD in a cohort of short children and adolescents with suspected growth disorder. However, performance of IGFBP-3 in this context was not statistically superior to ALS.This publication has 27 references indexed in Scilit:
- Austrian height and body proportion references for children aged 4 to under 19 yearsAnnals of Human Biology, 2013
- Auxology-based cut-off values for biochemical testing of GH secretion in childhoodGrowth Hormone & IGF Research, 2011
- The current status of IGF-I assays – A 2009 updateGrowth Hormone & IGF Research, 2010
- Developing evidence-based guidelines for referral for short statureArchives of Disease in Childhood, 2008
- Sample pre-treatment determines the clinical usefulness of acid-labile subunit immunoassays in the diagnosis of growth hormone deficiency and acromegalyActa Endocrinologica, 2007
- Inaccuracy of Insulin-Like Growth Factor (IGF) Binding Protein (IGFBP)-3 Assessment in the Diagnosis of Growth Hormone (GH) Deficiency from Childhood to Young Adulthood: Association to Low GH Dependency of IGF-II and Presence of Circulating IGFBP-3 18-Kilodalton FragmentJournal of Clinical Endocrinology & Metabolism, 2005
- Predictive accuracy and explained variationStatistics in Medicine, 2003
- Acid-Labile Subunit in Growth Hormone Excess and Deficiency in Adults: Evaluation of Its Diagnostic Value in Comparison with Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein-3.Endocrine Journal, 2002
- Is IGF binding protein‐3 assessment helpful for the diagnosis of GH deficiency?Clinical Endocrinology, 1995
- Insulin-Like Growth Factor Binding Proteins in the Human Circulation: A ReviewHormone Research, 1994